{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:09:58Z","timestamp":1759342198505,"version":"3.40.3"},"publisher-location":"Cham","reference-count":23,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030787868"},{"type":"electronic","value":"9783030787875"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-78787-5_52","type":"book-chapter","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T17:02:58Z","timestamp":1642006978000},"page":"415-422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Photo-Oxygenation: An Innovative New Therapeutic Approach Against Amyloidoses"],"prefix":"10.1007","author":[{"given":"Tetsuo","family":"Ikeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Hori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youhei","family":"Sohma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motomu","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taisuke","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,12]]},"reference":[{"key":"52_CR1","doi-asserted-by":"publisher","unstructured":"Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease. Neurology. https:\/\/doi.org\/10.1212\/wnl.42.3.6","DOI":"10.1212\/wnl.42.3.6"},{"key":"52_CR2","doi-asserted-by":"publisher","unstructured":"Braak H, Braak E (1995) Staging of alzheimer\u2019s disease-related neurofibrillary changes. Neurobiol Aging. https:\/\/doi.org\/10.1016\/0197-4580(95)00021-6","DOI":"10.1016\/0197-4580(95)00021-6"},{"key":"52_CR3","doi-asserted-by":"publisher","unstructured":"Buckner RL, Sepulcre J, Talukdar T, Krienen FM, Liu H, Hedden T, Andrews-Hanna JR, Sperling RA, Johnson KA (2009) Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer\u2019s disease. J Neurosci. https:\/\/doi.org\/10.1523\/JNEUROSCI.5062-08.2009","DOI":"10.1523\/JNEUROSCI.5062-08.2009"},{"key":"52_CR4","doi-asserted-by":"publisher","unstructured":"Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, Fraser G, Stalder AK, Beibel M, Staufenbiel M, Jucker M, Goedert M, Tolnay M (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol. https:\/\/doi.org\/10.1038\/ncb1901","DOI":"10.1038\/ncb1901"},{"key":"52_CR5","doi-asserted-by":"publisher","unstructured":"De Calignon A, Polydoro M, Su\u00e1rez-Calvet M, William C, Adamowicz DH, Kopeikina KJ, Pitstick R, Sahara N, Ashe KH, Carlson GA, Spires-Jones TL, Hyman BT (2012) Propagation of tau pathology in a model of early Alzheimer\u2019s disease. Neuron. https:\/\/doi.org\/10.1016\/j.neuron.2011.11.033","DOI":"10.1016\/j.neuron.2011.11.033"},{"key":"52_CR6","doi-asserted-by":"publisher","unstructured":"Frost B, Diamond MI (2010) Prion-like mechanisms in neurodegenerative diseases. Nat Rev Neurosci. https:\/\/doi.org\/10.1038\/nrn2786","DOI":"10.1038\/nrn2786"},{"key":"52_CR7","doi-asserted-by":"publisher","unstructured":"Goedert M, Spillantini MG (2006) A century of Alzheimer\u2019s disease. Science. https:\/\/doi.org\/10.1126\/science.1132814","DOI":"10.1126\/science.1132814"},{"key":"52_CR8","doi-asserted-by":"publisher","unstructured":"Hou L, Kang I, Marchant RE, Zagorski MG (2002) Methionine 35 oxidation reduces fibril assembly of the amyloid a\u03b2-(1-42) peptide of Alzheimer\u2019s disease. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.C200338200","DOI":"10.1074\/jbc.C200338200"},{"key":"52_CR9","doi-asserted-by":"publisher","unstructured":"Johansson AS, Bergquist J, Volbracht C, P\u00e4ivi\u00f6 A, Leist M, Lannfelt L, Westlind-Danielsson A (2007) Attenuated amyloid-\u03b2 aggregation and neurotoxicity owing to methionine oxidation. Neuroreport. https:\/\/doi.org\/10.1097\/WNR.0b013e3280b07c21","DOI":"10.1097\/WNR.0b013e3280b07c21"},{"key":"52_CR10","doi-asserted-by":"crossref","unstructured":"Ozawa S, Hori Y, Shimizu Y, Taniguchi A, Suzuki T, Wang W, Chiu YW, Koike R, Yokoshima S, Fukuyama T, Takatori S, Sohma Y, Kanai M, Tomita T (2021) Photo-oxygenation by a biocompatible catalyst reduces amyloid-\u03b2 levels in Alzheimer\u2019s disease mice. Brain. https:\/\/doi.org\/10.1093\/brain\/awab058.","DOI":"10.1093\/brain\/awab058"},{"key":"52_CR11","doi-asserted-by":"publisher","unstructured":"Plant\u00e9-Bordeneuve V, Ferreira A, Lalu T, Zaros C, Lacroix C, Adams D, Said G (2007) Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP). Neurology. https:\/\/doi.org\/10.1212\/01.wnl.0000267338.45673.f4","DOI":"10.1212\/01.wnl.0000267338.45673.f4"},{"key":"52_CR12","doi-asserted-by":"publisher","unstructured":"Porta S, Xu Y, Restrepo CR, Kwong LK, Zhang B, Brown HJ, Lee EB, Trojanowski JQ, Lee VMY (2018) Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-018-06548-9","DOI":"10.1038\/s41467-018-06548-9"},{"key":"52_CR13","doi-asserted-by":"publisher","unstructured":"Reiman EM, Quiroz YT, Fleisher AS, Chen K, Velez-Pardo C, Jimenez-Del-Rio M, Fagan AM, Shah AR, Alvarez S, Arbelaez A, Giraldo M, Acosta-Baena N, Sperling RA, Dickerson B, Stern CE, Tirado V, Munoz C, Reiman RA, Huentelman MJ et al (2012) Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer\u2019s disease in the presenilin E280A kindred: a case-control study. Lancet Neurol. https:\/\/doi.org\/10.1016\/S1474-4422(12)70228-4","DOI":"10.1016\/S1474-4422(12)70228-4"},{"key":"52_CR14","doi-asserted-by":"publisher","unstructured":"Saito T, Matsuba Y, Mihira N, Takano J, Nilsson P, Itohara S, Iwata N, Saido TC (2014) Single App knock-in mouse models of Alzheimer\u2019s disease. Nat Neurosci. https:\/\/doi.org\/10.1038\/nn.3697","DOI":"10.1038\/nn.3697"},{"key":"52_CR15","doi-asserted-by":"publisher","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med. https:\/\/doi.org\/10.15252\/emmm.201606210","DOI":"10.15252\/emmm.201606210"},{"key":"52_CR16","doi-asserted-by":"publisher","unstructured":"Serpell LC, Smith JM (2000) Direct visualisation of the \u03b2-sheet structure of synthetic Alzheimer\u2019s amyloid. J Mol Biol. https:\/\/doi.org\/10.1006\/jmbi.2000.3650","DOI":"10.1006\/jmbi.2000.3650"},{"key":"52_CR17","doi-asserted-by":"publisher","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M et al (2011) Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.003","DOI":"10.1016\/j.jalz.2011.03.003"},{"key":"52_CR18","doi-asserted-by":"publisher","unstructured":"Sperling R, Mormino E, Johnson K (2014) The evolution of preclinical Alzheimer\u2019s disease: implications for prevention trials. Neuron. https:\/\/doi.org\/10.1016\/j.neuron.2014.10.038","DOI":"10.1016\/j.neuron.2014.10.038"},{"key":"52_CR19","doi-asserted-by":"publisher","unstructured":"Suzuki T, Hori Y, Sawazaki T, Shimizu Y, Nemoto Y, Taniguchi A, Ozawa S, Sohma Y, Kanai M, Tomita T (2019) Photo-oxygenation inhibits tau amyloid formation. Chem Commun. https:\/\/doi.org\/10.1039\/c9cc01728c","DOI":"10.1039\/c9cc01728c"},{"key":"52_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201308001","volume-title":"Attenuation of the aggregation and neurotoxicity of amyloid-b peptides by catalytic photooxygenation","author":"A Taniguchi","year":"2014","unstructured":"Taniguchi A, Sasaki D, Shiohara A, Iwatsubo T, Tomita T, Sohma Y, Kanai M (2014) Attenuation of the aggregation and neurotoxicity of amyloid-b peptides by catalytic photooxygenation. Angewandte Chemie \u2013 International Edition. https:\/\/doi.org\/10.1002\/anie.201308001"},{"key":"52_CR21","doi-asserted-by":"crossref","unstructured":"Jeff, Sevigny Ping, Chiao T, Bussi\u00e8re PH, Weinreb L, Williams M, Maier R, Dunstan S, Salloway T, Chen Y, Ling J, O\u2019Gorman F, Qian M, Arastu M, Li S, Chollate MS, Brennan O, Quintero-Monzon RH, Scannevin H. Moore, Arnold T, Engber K, Rhodes J, Ferrero Y, Hang A, Mikulskis J, Grimm C, Hock RM, Nitsch A, Sandrock (2016) The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature 537(7618) 50\u201356. https:\/\/doi.org\/10.1038\/nature19323","DOI":"10.1038\/nature19323"},{"key":"52_CR22","doi-asserted-by":"crossref","unstructured":"Atsuhiko, Taniguchi Y, Shimizu K, Oisaki Y, Sohma M, Kanai (2016) Switchable photooxygenation catalysts that sense higher-order amyloid structures. Nature Chemistry 8(10) 974\u2013982. https:\/\/doi.org\/10.1038\/nchem.2550","DOI":"10.1038\/nchem.2550"},{"key":"52_CR23","doi-asserted-by":"crossref","unstructured":"Jizhi, Ni A, Taniguchi S, Ozawa Y, Hori Y, Kuninobu T, Saito TC, Saido T, Tomita Y, Sohma M, Kanai (2018) Near-Infrared Photoactivatable Oxygenation Catalysts of Amyloid Peptide. Chem 4(4) 807\u2013820. https:\/\/doi.org\/10.1016\/j.chempr.2018.02.008","DOI":"10.1016\/j.chempr.2018.02.008"}],"container-title":["Advances in Experimental Medicine and Biology","GeNeDis 2020"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-78787-5_52","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T03:48:23Z","timestamp":1651981703000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-78787-5_52"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030787868","9783030787875"],"references-count":23,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-78787-5_52","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"12 January 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}